WUXI BIOLOGICS CAYMAN INC USD0000025 144A REG S ISIN KYG9700 - G97008109
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GILDER GAGNON HOWE & CO LLC | History | Reduced | 3,073,012 | 74,783 | 0.46% | 0.44% | 1 | -13,191 | -0.43% | Q3 2020 | Nov 16, 2020 |